Earnings call transcript: ResMed surpasses Q2 FY2025 expectations, stock dips
ResMed Inc . (NYSE:RMD) reported its financial results for the second quarter of fiscal year 2025, exceeding analysts' expectations with an earnings per share (EPS) of $2.43, surpassing the forecasted ...
ResMed, In A Buy Zone, Whipsaws Despite Strong Profit Beat
The S&P 500 (SNPINDEX: ^GSPC) is widely considered the best gauge for the overall U.S. stock market. The index surged 23% in ...